Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the 10 Year Cancer Plan will include specific plans for expanding the availability of radiotherapy for cancer patients.
Answered by Helen Whately - Shadow Secretary of State for Transport
Following the call for evidence for a ten year cancer plan earlier this year, we received over 5,000 submissions. We are currently reviewing these responses.
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department will publish a 10-year Cancer Plan.
Answered by Helen Whately - Shadow Secretary of State for Transport
Following the call for evidence for a ten year cancer plan earlier this year, we received over 5,000 submissions. We are currently reviewing these responses.
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, how his Department determines Attendance Allowance rates for people of state pension age or over who have long-term medical conditions such as Parkinson’s.
Answered by Laura Trott - Shadow Chief Secretary to the Treasury
Attendance Allowance is intended to help those with a severe disability who have long term care or supervision needs after they reach State Pension age. It provides a contribution towards the extra costs they face because of those care or supervision needs. It is also paid in addition to other support they may receive, whether that be through benefits, the NHS or Local Authorities.
Recipients will include people who have long-term health conditions, such as Parkinson’s disease. Entitlement to Attendance Allowance is based upon the care needs that the person may have as a result of their disability and is not specifically linked to the disability itself. Attendance Allowance is paid at different rates, with the higher rate paid to those who need help or supervision throughout both day and night. Most awards are made for an indefinite period, recognising it is a benefit intended to help those with long term care needs. Those getting the higher rate are receiving around £5300 a year, tax free, which can be paid in addition to other support a pensioner may receive such as the State Pension and Pension Credit. Attendance Allowance is increased each April in line with inflation as measured by the Consumer Prices Index (CPI) for the previous September. The September 2022 CPI was 10.1 per cent which means that the rates of Attendance Allowance are due to be increased from April 2023 by this amount.
The lower rate of Attendance Allowance will increase from £61.85 to £68.10 and the higher rate will increase from £92.40 to £101.75. This is around an additional £1050 and £1600 a year respectively for disabled pensioners since 2010.
In addition, in 2022/23 and 2023/24 people in receipt of Attendance Allowance are entitled to a £150 disability cost of living payment, in addition to the pensioner cost of living payment of £300 per household. If they are in receipt of Pension Credit, they will also receive further cost of living payments worth up to £650 in 2022/23 and up to £900 in 2023/24. This is in addition to other measures announced during the Autumn Statement, such as the amended Energy Price Guarantee from April 2023 which will save also the average UK household £500 in 2023-24
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, if he will make it his policy to assess the adequacy of Attendance Allowance payments in providing support to people of state pension age or over, who have long-term conditions such as Parkinson’s.
Answered by Laura Trott - Shadow Chief Secretary to the Treasury
Attendance Allowance is intended to help those with a severe disability who have long term care or supervision needs after they reach State Pension age. It provides a contribution towards the extra costs they face because of those care or supervision needs. It is also paid in addition to other support they may receive, whether that be through benefits, the NHS or Local Authorities.
Recipients will include people who have long-term health conditions, such as Parkinson’s disease. Entitlement to Attendance Allowance is based upon the care needs that the person may have as a result of their disability and is not specifically linked to the disability itself. Attendance Allowance is paid at different rates, with the higher rate paid to those who need help or supervision throughout both day and night. Most awards are made for an indefinite period, recognising it is a benefit intended to help those with long term care needs. Those getting the higher rate are receiving around £5300 a year, tax free, which can be paid in addition to other support a pensioner may receive such as the State Pension and Pension Credit. Attendance Allowance is increased each April in line with inflation as measured by the Consumer Prices Index (CPI) for the previous September. The September 2022 CPI was 10.1 per cent which means that the rates of Attendance Allowance are due to be increased from April 2023 by this amount.
The lower rate of Attendance Allowance will increase from £61.85 to £68.10 and the higher rate will increase from £92.40 to £101.75. This is around an additional £1050 and £1600 a year respectively for disabled pensioners since 2010.
In addition, in 2022/23 and 2023/24 people in receipt of Attendance Allowance are entitled to a £150 disability cost of living payment, in addition to the pensioner cost of living payment of £300 per household. If they are in receipt of Pension Credit, they will also receive further cost of living payments worth up to £650 in 2022/23 and up to £900 in 2023/24. This is in addition to other measures announced during the Autumn Statement, such as the amended Energy Price Guarantee from April 2023 which will save also the average UK household £500 in 2023-24
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department will take to increase cancer treatment capacity in the NHS.
Answered by Helen Whately - Shadow Secretary of State for Transport
The ‘Delivery plan for tackling the COVID-19 backlog of elective care’ sets out how the National Health Service will recover and expand elective services over the next three years, including cancer services. The plan states the ambition that the number of people waiting more than 62 days to start treatment following suspected cancer will return to pre-pandemic levels by March 2023. We have allocated more than £8 billion from 2022/23 to 2024/25, in addition to the £2 billion Elective Recovery Fund and £700 million Targeted Investment Fund already made available in 2021/2022 to increase elective activity, including cancer services.
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help reduce waiting times for cancer treatment.
Answered by Helen Whately - Shadow Secretary of State for Transport
The ‘Delivery plan for tackling the COVID-19 backlog of elective care’ sets out how the National Health Service will recover and expand elective services over the next three years, including cancer services. The plan states the ambition that the number of people waiting more than 62 days to start treatment following suspected cancer will return to pre-pandemic levels by March 2023. We have allocated more than £8 billion from 2022/23 to 2024/25, in addition to the £2 billion Elective Recovery Fund and £700 million Targeted Investment Fund already made available in 2021/2022 to increase elective activity, including cancer services.
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department for Environment, Food and Rural Affairs:
To ask the Secretary of State for Environment, Food and Rural Affairs, whether he plans to consult on the ending of farrowing crates for pigs in context of the EU Commission's announcement of intention to propose legislation in that area.
Answered by Mark Spencer
The Government is committed to exploring the phasing out of farrowing crates, supporting the industry to do so in a way which underpins UK food production and does not have unintended animal welfare or business impacts.
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, whether he has made an assessment with Cabinet colleagues of the potential impact of the cost of living crisis on the financial well-being of people with Parkinson’s.
Answered by John Glen - Shadow Paymaster General
The Government recognises that the rising cost of living has presented additional financial challenges to many people, and especially to the most vulnerable members of society, such as disabled people and people with long-term health conditions. That is why the Government is taking decisive action to support households while ensuring we act in a fiscally responsible way.
If individuals have extra-costs arising from their Parkinson’s disease, then they may qualify for disability benefits such as Personal Independence Payment (PIP). At Autumn Statement 2022, the Government announced that it will provide a further Disability Cost of Living Payment of £150 in 2023/24 to people in receipt of extra-costs disability benefits such as PIP or Disability Living Allowance (DLA). This is additional to the £150 payment for recipients of disability benefits in 2022 already announced as part of the Cost of Living package in May.
These payments can be received in addition to the other Cost of Living Payments for households on means-tested benefits, namely the £650 payment announced in May and the additional £900 payment announced at Autumn Statement. Individuals who have limited or no ability to work because of their disability or long-term health condition, and are in receipt of means-tested benefits such as income-related Employment and Support Allowance or the Universal Credit Health top up, are eligible for this support.
Those living with a long-term health condition, such as Parkinson’s disease, can also benefit from other forms of non-means-tested support which the Government is providing to assist with UK households’ energy bills. We have taken decisive action to support millions of households with rising energy costs through the Energy Price Guarantee, which limits the price suppliers can charge customers for units of gas and electricity. In addition to the Energy Price Guarantee, millions of the most vulnerable households will receive further support this year through the £400 Energy Bills Support Scheme. The £150 Council Tax rebate will also mean that all households in Council Tax bands A-D will receive a rebate, and 99% of eligible households have already received this.
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what progress his Department has made on meeting his NHS Planning Guidance target of 25% of outpatient attendances being delivered remotely by telephone or video consultation.
Answered by Will Quince
NHS England is monitoring the use of virtual consultations as part of the Outpatients Transformation Programme. During 2021/22, there were 5.3 million first tele-consultations and 16.6 million subsequent tele-consultations, protecting access to services and reducing pressures on hospital outpatient clinics. In 2021/22, approximately 23% of all attendances were conducted by virtual consultation.
Asked by: Caroline Dinenage (Conservative - Gosport)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the effect of the EU Medical Devices Regulations assessment system on the availability medical device and health tech products in the UK; and what steps he is taking to provide patients in the UK with equal access to medical devices and health tech through the delivery of an effective UKCA marking system.
Answered by Will Quince
The future medical devices regime is an overhaul of the current regulatory framework, aimed at improving safety and incorporating measures to encourage innovation and offer alternative routes to market. This includes domestic assurance, which will allow an abridged assessment with the appropriate scrutiny and United Kingdom approved bodies can reject applications under the domestic assurance route if the evidence provided is insufficiently robust. A number of countries will be considered for the domestic assurance route, including the United States of America.
The Medicines and Healthcare products Regulatory Agency (MHRA) is working to build closer partnerships with global regulators and has established full membership of the International Medical Device Regulations Forum (IMDRF) and is an official observer of the Medical Devices Single Audit Programme (MDSAP), of which the US Food and Drug Administration is a member. The MHRA is engaging with the FDA within international fora and on a bilateral basis.
The transitional arrangements for medical devices are intended to minimise the risks to access for patients in the UK and facilitate the transition between the current and new regulatory framework whilst supporting the ongoing safe supply of essential medical devices. CE marked devices under the new European Union regulations will continue to be placed onto the UK market when the new regime comes into force for up to a period of five years, with a view to review this provision at the end of the five-year period. It is not anticipated that an extension of this provision will be required, as the intervening period will be used to support an increase in approved body capacity to ensure the UK has sufficient capacity to transition all medical devices to the UKCA marking system. The MHRA will work with international regulators to place the UKCA marking for medical devices on a global standing.